메뉴 건너뛰기




Volumn 66, Issue 3, 2011, Pages 611-617

Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model

Author keywords

Aztreonam; Ertapenem; Imipenem; Meropenem; VIM

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; TOBRAMYCIN;

EID: 79951544289     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq470     Document Type: Article
Times cited : (21)

References (22)
  • 1
    • 33847377956 scopus 로고    scopus 로고
    • Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
    • Cornaglia G, Akova M, Amicosante G et al. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 2007; 29: 380-8.
    • (2007) Int J Antimicrob Agents , vol.29 , pp. 380-388
    • Cornaglia, G.1    Akova, M.2    Amicosante, G.3
  • 2
    • 40749134174 scopus 로고    scopus 로고
    • Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
    • Souli M, Kontopidou FV, Papadomichelakis E et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital. Clin Infect Dis 2008; 46: 847-54.
    • (2008) Clin Infect Dis , vol.46 , pp. 847-854
    • Souli, M.1    Kontopidou, F.V.2    Papadomichelakis, E.3
  • 3
    • 66149110334 scopus 로고    scopus 로고
    • Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections
    • Daikos GL, Petrikkos P, Psichogiou M et al. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009; 53: 1868-73.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1868-1873
    • Daikos, G.L.1    Petrikkos, P.2    Psichogiou, M.3
  • 4
    • 74549182171 scopus 로고    scopus 로고
    • Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
    • Miriagou V, Cornaglia G, Edelstein M et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010; 16: 112-22.
    • (2010) Clin Microbiol Infect , vol.16 , pp. 112-122
    • Miriagou, V.1    Cornaglia, G.2    Edelstein, M.3
  • 6
    • 74549155155 scopus 로고    scopus 로고
    • Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
    • Carmeli Y, Akova M, Cornaglia G et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16: 102-11.
    • (2010) Clin Microbiol Infect , vol.16 , pp. 102-111
    • Carmeli, Y.1    Akova, M.2    Cornaglia, G.3
  • 8
    • 0035262126 scopus 로고    scopus 로고
    • Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species
    • Lee K, Chong Y, Shin HB et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2000; 7: 88-91.
    • (2000) Clin Microbiol Infect , vol.7 , pp. 88-91
    • Lee, K.1    Chong, Y.2    Shin, H.B.3
  • 9
    • 0034023159 scopus 로고    scopus 로고
    • Characterization of VIM-2, a carbapenemhydrolysing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
    • Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenemhydrolysing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891-7.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 891-897
    • Poirel, L.1    Naas, T.2    Nicolas, D.3
  • 10
    • 4243894113 scopus 로고
    • Assay of antimicrobials
    • Lennette EH, Balows A, Hausler Jr et al., eds. Washington, DC: American Society for Microbiology
    • Sabath LD, Anhalt JP. Assay of antimicrobials. In: Lennette EH, Balows A, Hausler Jr et al., eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1980; 485-90.
    • (1980) Manual of Clinical Microbiology , pp. 485-490
    • Sabath, L.D.1    Anhalt, J.P.2
  • 11
    • 44949156232 scopus 로고    scopus 로고
    • Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis
    • Tsaganos T, Kouki P, Digenis P et al. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis. Int J Infect Dis 2008; 32: 46-9.
    • (2008) Int J Infect Dis , vol.32 , pp. 46-49
    • Tsaganos, T.1    Kouki, P.2    Digenis, P.3
  • 12
    • 0344146475 scopus 로고    scopus 로고
    • Activities of the oxazolidinones linezolid and eperezolid in experimental inta-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium
    • Schulin T, Thauvin-Eliopoulos C, Moellering RC et al. Activities of the oxazolidinones linezolid and eperezolid in experimental inta-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1999; 43: 2873-6.
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 2873-2876
    • Schulin, T.1    Thauvin-Eliopoulos, C.2    Moellering, R.C.3
  • 13
    • 35948970570 scopus 로고    scopus 로고
    • Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
    • Sakka SG, Glauner AK, Bulitta JB et al. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother 2007; 51: 3304-10.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3304-3310
    • Sakka, S.G.1    Glauner, A.K.2    Bulitta, J.B.3
  • 14
    • 0345130000 scopus 로고    scopus 로고
    • Continuous infusion versus intermittent administration of meropenem in critically ill patients
    • Thalhammer F, Traunmüller F, El Menyawi I et al. Continuous infusion versus intermittent administration of meropenem in critically ill patients. J Antimicrob Chemother 1999; 43: 523-7.
    • (1999) J Antimicrob Chemother , vol.43 , pp. 523-527
    • Thalhammer, F.1    Traunmüller, F.2    El Menyawi, I.3
  • 15
    • 3042637085 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians
    • Nix DE, Majumdar AK, DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother 2004; 53 Suppl 2: ii23-8.
    • (2004) J Antimicrob Chemother , vol.53 , Issue.SUPPL. 2
    • Nix, D.E.1    Majumdar, A.K.2    DiNubile, M.J.3
  • 16
    • 35948951943 scopus 로고    scopus 로고
    • Parmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation
    • Vinks AA, van Rossem RN, Mathôt RAA et al. Parmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation. Antimicrob Agents Chemother 2007; 51: 3049-55.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3049-3055
    • Vinks, A.A.1    van Rossem, R.N.2    Mathôt, R.A.A.3
  • 17
    • 44449116776 scopus 로고    scopus 로고
    • High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence
    • pii=8023
    • Vatopoulos A. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill 2008; 13: pii=8023.
    • (2008) Euro Surveill , pp. 13
    • Vatopoulos, A.1
  • 18
    • 0036751668 scopus 로고    scopus 로고
    • Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece
    • Galani I, Xirouchaki E, Kanellakopoulou K et al. Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin Microbiol Infect 2002; 8: 579-88.
    • (2002) Clin Microbiol Infect , vol.8 , pp. 579-588
    • Galani, I.1    Xirouchaki, E.2    Kanellakopoulou, K.3
  • 19
    • 0037439449 scopus 로고    scopus 로고
    • Prevention of resistance: a goal for dose selection for antimicrobial agents
    • Drusano GL. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin Infect Dis 2000; 36 Suppl 2: 42-50.
    • (2000) Clin Infect Dis , vol.36 , Issue.SUPPL. 2 , pp. 42-50
    • Drusano, G.L.1
  • 20
    • 33846296202 scopus 로고    scopus 로고
    • Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model
    • Daikos GL, Panagiotakopoulou A, Tzelepi E et al. Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model. Clin Microbiol Infect 2007; 13: 202-5.
    • (2007) Clin Microbiol Infect , vol.13 , pp. 202-205
    • Daikos, G.L.1    Panagiotakopoulou, A.2    Tzelepi, E.3
  • 21
    • 34248210168 scopus 로고    scopus 로고
    • Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece
    • Galani I, Souli M, Koratzanis E et al. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J Antimicrob Chemother 2007; 59: 578-9.
    • (2007) J Antimicrob Chemother , vol.59 , pp. 578-579
    • Galani, I.1    Souli, M.2    Koratzanis, E.3
  • 22
    • 18844420212 scopus 로고    scopus 로고
    • VIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece
    • VIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece. J Antimicrob Chemother 2005; 55: 634-8.
    • (2005) J Antimicrob Chemother , vol.55 , pp. 634-638
    • Galani, I.1    Souli, M.2    Chryssouli, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.